{"id":"https://openalex.org/W2496717359","doi":"https://doi.org/10.1055/s-0042-102801","title":"PCSK9-Inhibitoren \u2013 Durchbruch bei der LDL-Cholesterin-Senkung?","display_name":"PCSK9-Inhibitoren \u2013 Durchbruch bei der LDL-Cholesterin-Senkung?","publication_year":2016,"publication_date":"2016-06-15","ids":{"openalex":"https://openalex.org/W2496717359","doi":"https://doi.org/10.1055/s-0042-102801","mag":"2496717359","pmid":"https://pubmed.ncbi.nlm.nih.gov/27305302"},"language":"de","primary_location":{"id":"doi:10.1055/s-0042-102801","doi":"https://doi.org/10.1055/s-0042-102801","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0042-102801","pdf_url":null,"source":{"id":"https://openalex.org/S38943393","display_name":"DMW - Deutsche Medizinische Wochenschrift","issn_l":"0012-0472","issn":["0012-0472","1439-4413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"DMW - Deutsche Medizinische Wochenschrift","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111740566","display_name":"K Richter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kurt Richter","raw_affiliation_strings":["Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I78650965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109574864","display_name":"Andreas Barthel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Barthel","raw_affiliation_strings":["Endokrinologikum Ruhr, Bochum","Medizinische Klinik und Poliklinik III, Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endokrinologikum Ruhr, Bochum","institution_ids":[]},{"raw_affiliation_string":"Medizinische Klinik und Poliklinik III, Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I4210162051","https://openalex.org/I78650965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006906048","display_name":"Stefan Richard Bornstein","orcid":"https://orcid.org/0000-0002-5211-2536","observed_orcids":["https://orcid.org/0000-0002-5211-2536"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I3018134672","display_name":"Helmholtz Munich","ror":"https://ror.org/00cfam450","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I3018134672"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I4210164390","display_name":"Paul Langerhans Institute Dresden","ror":"https://ror.org/05ke5hb07","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I3018134672","https://openalex.org/I4210162051","https://openalex.org/I4210164390","https://openalex.org/I78650965"]},{"id":"https://openalex.org/I4405266872","display_name":"Center for Regenerative Therapies Dresden","ror":"https://ror.org/00490nx58","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4405266872","https://openalex.org/I4405279746","https://openalex.org/I78650965"]},{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE","GB"],"is_corresponding":false,"raw_author_name":"Stefan Bornstein","raw_affiliation_strings":["DFG Center for Regenerative Therapies, Technische Universit\u00e4t Dresden, Dresden","Department of Diabetes and Endocrinology, Divison of Diabetes and Nutritional Sciences, King\u2019s College, London, UK","Medizinische Klinik und Poliklinik III, Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden","Paul-Langerhans-Institut f\u00fcr Diabetesforschung des Helmholtz Zentrums M\u00fcnchen am Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DFG Center for Regenerative Therapies, Technische Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I4405266872","https://openalex.org/I78650965"]},{"raw_affiliation_string":"Department of Diabetes and Endocrinology, Divison of Diabetes and Nutritional Sciences, King\u2019s College, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Medizinische Klinik und Poliklinik III, Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I4210162051","https://openalex.org/I78650965"]},{"raw_affiliation_string":"Paul-Langerhans-Institut f\u00fcr Diabetesforschung des Helmholtz Zentrums M\u00fcnchen am Universit\u00e4tsklinikum Carl Gustav Carus an der Technischen Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I3018134672","https://openalex.org/I4210164390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059035028","display_name":"Ali El\u2010Armouche","orcid":"https://orcid.org/0000-0003-2514-9429","observed_orcids":["https://orcid.org/0000-0003-2514-9429"]},"institutions":[{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Ali El-Armouche","raw_affiliation_strings":["Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I78650965"]}]},{"author_position":"last","author":{"id":null,"display_name":"Michael Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Wagner","raw_affiliation_strings":["Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden","institution_ids":["https://openalex.org/I78650965"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5059035028"],"corresponding_institution_ids":["https://openalex.org/I78650965"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.11312469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"141","issue":"12","first_page":"863","last_page":"869"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.75},{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.7749999761581421},{"id":"https://openalex.org/keywords/ldl-receptor","display_name":"LDL receptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":0.8270000219345093},{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":1.0},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8960000276565552},{"id":"https://openalex.org/keywords/ldl-receptor-recycling","display_name":"LDL receptor recycling","score":0.5490000247955322},{"id":"https://openalex.org/keywords/statin-naive-patients","display_name":"statin-naive patients","score":0.656000018119812},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.6710000038146973},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6449999809265137},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.5959479808807373},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5232640504837036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27541911602020264}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1055/s-0042-102801","doi":"https://doi.org/10.1055/s-0042-102801","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0042-102801","pdf_url":null,"source":{"id":"https://openalex.org/S38943393","display_name":"DMW - Deutsche Medizinische Wochenschrift","issn_l":"0012-0472","issn":["0012-0472","1439-4413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"DMW - Deutsche Medizinische Wochenschrift","raw_type":"journal-article"},{"id":"pmid:27305302","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27305302","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Deutsche medizinische Wochenschrift (1946)","raw_type":"Journal Article"},{"id":"pmh:oai:opus-zb.helmholtz-muenchen.de:49014","doi":null,"is_oa":false,"landing_page_url":"https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=49014","pdf_url":null,"source":{"id":"https://openalex.org/S4377196115","display_name":"Site cant be reached","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dtsch. Med. Wochenschr. 141, 863-869 (2016)","raw_type":null},{"id":"pmh:oai:push-zb.helmholtz-munich.de:49014","doi":null,"is_oa":false,"landing_page_url":"https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49014","pdf_url":null,"source":{"id":"https://openalex.org/S7407055352","display_name":"PuSH - Publication Server of Helmholtz Zentrum M\u00fcnchen","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dtsch. Med. Wochenschr. 141, 863-869 (2016)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/187291","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/187291","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Richter, K., Barthel, A., Bornstein, S. R., El-Armouche, A., & Wagner, M. (2016). PCSK9-Inhibitoren \u2013 Durchbruch bei der LDL-Cholesterin-Senkung? Deutsche Medizinische Wochenschrift, 141, 863\u2013869. https://doi.org/10.1055/s-0042-102801","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:208353","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/208353","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Richter, Kurt; Barthel, Andreas; Bornstein, Stefan R; El-Armouche, Ali; Wagner, Michael (2016). PCSK9-Inhibitoren \u2013 Durchbruch bei der LDL-Cholesterin-Senkung? Deutsche Medizinische Wochenschrift, 141(12):863-869.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088998164","https://openalex.org/W3103325438","https://openalex.org/W635875665","https://openalex.org/W2046996117","https://openalex.org/W2063942289","https://openalex.org/W4206107200","https://openalex.org/W2342735925","https://openalex.org/W2570382091","https://openalex.org/W2967853731","https://openalex.org/W2016195709"],"abstract_inverted_index":{"The":[0],"proprotein":[1],"convertase":[2],"subtilisin":[3],"/":[4],"kexin":[5],"type":[6],"9":[7],"(PCSK9)":[8],"plays":[9],"an":[10,85],"important":[11],"role":[12],"in":[13,22,84,106,113,132,178],"LDL":[14,43,88],"cholesterol":[15],"(LDL-C)":[16],"metabolism.":[17],"Subjects":[18],"harboring":[19],"loss-of-function":[20],"mutations":[21],"the":[23,38,42,52,56,74,98,153,159,171,186],"gene":[24],"encoding":[25],"for":[26],"PCSK9":[27,34,60,99,191],"display":[28],"markedly":[29],"reduced":[30],"LDL-C":[31,79,93,107],"plasma":[32],"levels.":[33],"is":[35],"secreted":[36],"by":[37,152],"liver,":[39],"binds":[40],"to":[41,110],"receptor":[44,53,75,89],"and,":[45],"following":[46],"endocytosis,":[47],"induces":[48],"lysosomal":[49],"degradation":[50],"of":[51,71,108,127,139,158,174,185,190],"together":[54],"with":[55],"bound":[57],"LDL-C.":[58],"Current":[59],"inhibitors":[61,100],"are":[62],"monoclonal":[63],"antibodies":[64],"that":[65],"specifically":[66],"absorb":[67],"PCSK9.":[68],"Subsequently,":[69],"instead":[70],"being":[72],"degraded":[73],"can":[76],"dissociate":[77],"from":[78],"and":[80,91,102,168,188],"recycle,":[81],"consecutively":[82],"resulting":[83],"increased":[86],"hepatocyte":[87],"density":[90],"higher":[92],"clearance.":[94],"In":[95],"clinical":[96],"trials,":[97],"alirocumab":[101],"evolocumab":[103],"induced":[104],"reductions":[105],"up":[109],"70":[111],"%":[112],"statin-treated":[114],"as":[115,117],"well":[116],"statin-na\u00efve":[118],"patients.":[119],"So":[120],"far,":[121],"serious":[122],"side":[123],"effects":[124],"(requiring":[125],"cessation":[126],"drug":[128],"treatment)":[129],"occurred":[130],"only":[131],"rare":[133],"cases.":[134],"Since":[135],"this":[136],"new":[137],"class":[138],"lipid":[140],"lowering":[141],"drugs":[142],"promises":[143],"a":[144,182],"high":[145],"potential":[146],"benefit,":[147],"they":[148],"have":[149],"been":[150],"approved":[151],"EMA":[154],"even":[155],"before":[156],"completion":[157],"studies":[160],"addressing":[161],"clinically":[162],"relevant":[163],"endpoints":[164],"like":[165],"cardiovascular":[166],"events":[167],"mortality.":[169],"Therefore,":[170],"expected":[172],"publication":[173],"these":[175],"study":[176],"results":[177],"2017":[179],"may":[180],"allow":[181],"better":[183],"assessment":[184],"efficacy":[187],"safety":[189],"inhibitors.":[192]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-08-23T00:00:00"}